Rhythm Pharmaceuticals
RYTM
RYTM
55 hedge funds and large institutions have $485M invested in Rhythm Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
28% less capital invested
Capital invested by funds: $672M → $485M (-$187M)
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Holders
55
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$6.76M | |
| 2 | +$2.37M | |
| 3 | +$1.99M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$1.34M |
| 5 |
JPMorgan Chase & Co
New York
|
+$786K |
Top Sellers
| 1 | -$4.21M | |
| 2 | -$3.04M | |
| 3 | -$2.94M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$2.77M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.61M |